# A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness

> **NCT03204487** · PHASE4 · COMPLETED · sponsor: **Ordination Dr. Hommer** · enrollment: 30 (actual)

## Conditions studied

- Glaucoma, Open-Angle
- Ocular Hypertension

## Interventions

- **DRUG:** Tafluprost 15µg/ml

## Key facts

- **NCT ID:** NCT03204487
- **Lead sponsor:** Ordination Dr. Hommer
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05-10
- **Primary completion:** 2017-04-25
- **Final completion:** 2017-06-30
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03204487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03204487, "A Study on the Effect of Changing From Preserved Prostaglandin Formulations to Preservative Free Tafluprost on Tear Film Thickness". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03204487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*